Amplify YieldShares Oil Hedged MLP Income ETF (AMLX) News
Filter AMLX News Items
AMLX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AMLX News Highlights
- For AMLX, its 30 day story count is now at 3.
- Over the past 15 days, the trend for AMLX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about AMLX are PAY.
Latest AMLX News From Around the Web
Below are the latest news stories about AMYLYX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate AMLX as an investment opportunity.
Is Amylyx (AMLX) Stock a Solid Choice Right Now?Amylyx (AMLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. |
Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)CAMBRIDGE, Mass., December 22, 2023--Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP) |
Implied Volatility Surging for Amylyx (AMLX) Stock OptionsInvestors need to pay close attention to Amylyx (AMLX) stock based on the movements in the options market lately. |
Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALSCAMBRIDGE, Mass., December 04, 2023--Amylyx Pharmaceuticals Announces Publication of Data Showing the Effect of AMX0035 on Plasma Neuroinflammatory Biomarkers in ALS |
Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., November 29, 2023--Amylyx Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
3 Top-Rated Biotech Stocks That Analysts Are Loving NowInvesting in biotech stocks can be tricky, but analysts have bullish outlooks on these three, promising companies. |
Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical OfficerCAMBRIDGE, Mass., November 28, 2023--Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as Chief Medical Officer |
RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MNDCAMBRIDGE, Mass., November 27, 2023--RELYVRIO® and AMX0114 Data to be Presented at 34th International Symposium on ALS/MND |
Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx ConferenceCAMBRIDGE, Mass., November 21, 2023--Amylyx Pharmaceuticals to Participate at the 6th Annual Evercore ISI HealthCONx Conference |
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call TranscriptAmylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions]. […] |